Cadrenal Therapeutics, Inc. — Form D

Cadrenal Therapeutics, Inc. of PONTE VEDRA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-14. The offering totals $9.4M, of which $9.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Robert W LisickiDirectorPonte Vedra, FL
Quang PhamDirectorPonte Vedra, FL
Glynn W WilsonDirectorPonte Vedra, FL
Steven W ZelenkofskeDirectorPonte Vedra, FL
Jeff W ColeExecutive OfficerPonte Vedra, FL
Douglas W LosordoExecutive OfficerPonte Vedra, FL
Quang PhamExecutive OfficerPonte Vedra, FL
Matthew SzotExecutive OfficerPonte Vedra, FL
JOHN R MURPHYDirectorPONTE VEDRA, FL
LEE S GOLDENDirectorPONTE VEDRA, FL
JEFFREY K COLEExecutive OfficerPONTE VEDRA, FL
QUANG X PHAMDirectorPONTE VEDRA, FL
QUANG X PHAMExecutive OfficerPONTE VEDRA, FL
JAMES J FERGUSONExecutive OfficerPONTE VEDRA, FL
GLYNN J WILSONDirectorPONTE VEDRA, FL
STEVEN J ZELENKOFSKEDirectorPONTE VEDRA, FL
Jeffrey ColeRelated PersonToronto, A6
John MurphyDirectorBeaver Falls, PA
Matthew SzotRelated PersonPonte Vedra, FL
Glynn WilsonDirectorPonte Vedra, FL
Glynn WilsonRelated PersonPonte Vedra, FL
STEVEN ZELENKOFSKEDirectorPonte Vedra, FL
STEVEN ZELENKOFSKERelated PersonPonte Vedra, FL
Douglas LosordoExecutive OfficerPONTE VEDRA, FL
JAMES FERGUSONRelated PersonPonte Vedra, FL

Other filings by this issuer (6)

FiledFormOfferingSold
2026-07-15D$8.8M$8.8M
2026-04-06D$7.9M$7.9M
2025-12-31D$4.4M$4.4M
2023-07-18D$7.5M$7.5M
2022-12-08D$1.0M$250K
2022-07-25D$2.0M$150K

More